rupatadine has been researched along with desloratadine in 12 studies
| Studies (rupatadine) | Trials (rupatadine) | Recent Studies (post-2010) (rupatadine) | Studies (desloratadine) | Trials (desloratadine) | Recent Studies (post-2010) (desloratadine) |
|---|---|---|---|---|---|
| 116 | 43 | 62 | 465 | 146 | 166 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| DeGraw, AJ; Distefano, MD; Keiser, MJ; Ochocki, JD; Shoichet, BK | 1 |
| Buschauer, A; Cuboni, S; Devigny, C; Eder, M; Hauger, B; Hausch, F; Höfner, G; Holsboer, F; Hoogeland, B; Pomplun, S; Strasser, A; Wanner, KT | 1 |
| Bosma, R; Bushby, N; de Esch, IJ; de Graaf, C; Kooistra, AJ; Kuhne, S; Leurs, R; Sheppard, RJ; van den Bor, J; Vischer, HF; Wang, Z; Waring, MJ; Wijtmans, M | 1 |
| Camelo-Nunes, IC | 1 |
| Carbó, ML; Izquierdo, I; Merlos, M; Nadal, T; Peña, J; Solans, A | 1 |
| Antonijoan, R; Barbanoj, M; Carbó, ML; Donado, E; Izquierdo, I; Merlos, M; Nadal, T; Peña, J; Solans, A | 1 |
| Fan, G; Hong, Z; Wei, H; Wen, J; Wu, Y | 1 |
| Srinivas, NR | 1 |
| Bennett, C; Carter, B; Cohen, SN; Sharma, M | 1 |
| Barkai, L; Izquierdo, I; Maurer, M; Mezei, G; Mitha, E; Potter, P; Santamaría, E | 1 |
| Antonijoan, R; Campo, C; Coimbra, J; García-Gea, C; Gich, I; Labeaga, L; Puntes, M; Valiente, R | 1 |
| Duman, N; Duman, R; Vurmaz, A | 1 |
2 review(s) available for rupatadine and desloratadine
| Article | Year |
|---|---|
New antihistamines: a critical view.
Topics: Anti-Allergic Agents; Blood-Brain Barrier; Central Nervous System Diseases; Cetirizine; Child; Cyproheptadine; Heart Diseases; Histamine H1 Antagonists, Non-Sedating; Humans; Hypersensitivity; Loratadine; Mast Cells; Piperazines; Receptors, Histamine H1; Terfenadine | 2006 |
H1-antihistamines for chronic spontaneous urticaria.
Topics: Cetirizine; Cyproheptadine; Histamine H1 Antagonists; Humans; Hydroxyzine; Loratadine; Randomized Controlled Trials as Topic; Urticaria | 2014 |
4 trial(s) available for rupatadine and desloratadine
| Article | Year |
|---|---|
Influence of food on the oral bioavailability of rupatadine tablets in healthy volunteers: a single-dose, randomized, open-label, two-way crossover study.
Topics: Adolescent; Adult; Area Under Curve; Biological Availability; Cross-Over Studies; Cyproheptadine; Female; Food-Drug Interactions; Histamine H1 Antagonists; Humans; Loratadine; Male; Tablets | 2007 |
Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Chromatography, High Pressure Liquid; Confidence Intervals; Cross-Over Studies; Cyproheptadine; Dose-Response Relationship, Drug; Drug Interactions; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Safety; Therapeutic Equivalency | 2008 |
Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years.
Topics: Age Factors; Child; Child, Preschool; Chronic Disease; Cyproheptadine; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Hungary; Loratadine; Male; Quality of Life; Remission Induction; South Africa; Time Factors; Treatment Outcome; Urticaria | 2016 |
Comparative efficacy of bilastine, desloratadine and rupatadine in the suppression of wheal and flare response induced by intradermal histamine in healthy volunteers.
Topics: Adult; Benzimidazoles; Cross-Over Studies; Cyproheptadine; Double-Blind Method; Female; Healthy Volunteers; Histamine; Histamine Antagonists; Humans; Injections, Intradermal; Loratadine; Male; Piperidines; Skin | 2017 |
6 other study(ies) available for rupatadine and desloratadine
| Article | Year |
|---|---|
Prediction and evaluation of protein farnesyltransferase inhibition by commercial drugs.
Topics: Animals; Cell Line; Dose-Response Relationship, Drug; Enzyme Inhibitors; Farnesyltranstransferase; Green Fluorescent Proteins; Histamine H1 Antagonists, Non-Sedating; Ligands; Loratadine; Miconazole; Microscopy, Confocal; Molecular Structure; Pharmaceutical Preparations; Protein Interaction Mapping; Protein Prenylation; ras Proteins; Recombinant Fusion Proteins; Technology, Pharmaceutical | 2010 |
Loratadine and analogues: discovery and preliminary structure-activity relationship of inhibitors of the amino acid transporter B(0)AT2.
Topics: Amino Acid Transport Systems, Neutral; Binding, Competitive; Brain; Cell Membrane; Chemistry, Pharmaceutical; Electrophysiology; Green Fluorescent Proteins; HEK293 Cells; Histamine H1 Antagonists, Non-Sedating; Humans; Inhibitory Concentration 50; Kinetics; Loratadine; Nerve Tissue Proteins; Patch-Clamp Techniques; Receptors, Histamine H1; Structure-Activity Relationship | 2014 |
Route to Prolonged Residence Time at the Histamine H
Topics: Cyproheptadine; Histamine H1 Antagonists; Humans; Kinetics; Loratadine; Molecular Docking Simulation; Protein Binding; Receptors, Histamine H1; Time Factors | 2019 |
Simultaneous determination of rupatadine and its metabolite desloratadine in human plasma by a sensitive LC-MS/MS method: application to the pharmacokinetic study in healthy Chinese volunteers.
Topics: Adult; Asian People; Calibration; Chromatography, Liquid; Cyproheptadine; Drug Stability; Female; Formates; Freezing; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Methanol; Molecular Structure; Platelet Activating Factor; Quality Control; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tablets; Tandem Mass Spectrometry; Time Factors; Water; Young Adult | 2009 |
Unsuspected polymorphic metabolism of rupatadine via its primary metabolite, desloratadine.
Topics: Cyproheptadine; Cytochrome P-450 CYP3A; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Mutation; Polymorphism, Single Nucleotide | 2009 |
Effects of second-generation H1-antihistamine drugs on angiogenesis in
Topics: Animals; Cetirizine; Chickens; Chorioallantoic Membrane; Histamine H1 Antagonists, Non-Sedating | 2023 |